Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
Lost evidence from registered large long-unpublished randomized controlled trials: a survey – Annals of Internal Medicine
Past studies have shown that many randomized controlled trials (RCTs) remain unpublished or unreported on ClinicalTrials.gov. Worried about the loss of information from these unpublished trials, researchers evaluated preregistered RCTs that were both unpublished and unreported on ClinicalTrials.gov for more than 46 months after completion.
Read the study via Annals of Internal Medicine
EudraCT public web report for April 2019 – European Medicines Agency
In its monthly web report, the EMA notes that a total of 56,851 clinical trials have been recorded in the EudraCT database, with 79% of the clinical trials having a commercial sponsor. Thus far in 2019, the total EudraCT Numbers issued is 1,651.
Read the full web report here
Event alert: Vivli’s annual meeting – Vivli
At this year’s annual meeting, the theme is “Working together to transform data sharing.” Panels and speakers will discuss challenges of sharing small datasets, rare disease data, informed consent, and more. The event is free, but registration is mandatory.
Register for the annual meeting here
